Secarna

Secarna Appoints Konstantin Petropoulos as CEO

Germany’s Secarna Pharmaceuticals has appointed Konstantin Petropoulos as CEO. He is stepping up from his previous role as the company’s chief business officer (CBO) and succeeds Alexander Gebauer, who is stepping down with immediate effect to focus his efforts on another company, Galimedix Therapeutics, that he has co-founded and is leading.

Celanese and Secarna Collaborate on Long-Acting Antisense Therapies

US chemical group Celanese and Germany’s Secarna Pharmaceuticals, an antisense drug discovery and development company, entered a research collaboration for the development of long-acting implants that deliver antisense oligonucleotides (ASOs).

Evotec Enters Multiple Drug Discovery Pacts

German drug discovery and development company Evotec has struck four separate partnership agreements during August.

Secarna and Lipigon Sign R&D Pact

Secarna and Firebrand in Cancer R&D pact